Results

Total Results: 658 records

Showing results for "mentioned".

1. Disposition of Comments_Comparative Effectiveness Review No. 245: Breast Reconstruction After Mastectomy (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/cer-245-breast-reconstruction-after-mastectomy-disposition-comments.pdf
   October 01, 2021 - General For example, the report barely mentions prophylactic mastectomies, and BRCA mutations are not mentioned … and the potential lethality of BIA-ALCL, that lymphoma, which is caused by breast implants, is only mentioned … BIA-ALCL was not mentioned as a risk in the section of the report comparing different types of implants … BIA-ALCL was not mentioned as a risk in the section of the report comparing different types of implants … Additionally, BRCA mutations are not mentioned in the report, despite being a key factor that influences

2. Evidence-based Practice Center Future Research Needs (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/ongoing-studies-evidence_research.pdf
   December 01, 2010 - trials’ data (mentioned by 2 respondents ) • Ability to customize the search and display (mentioned … ) • Out of date information (mentioned by 1 respondent) • Exporting results (mentioned by 1 respondent … ) • Limiting searches (mentioned by 1 respondent) • Overlap with ClinicalTrials.gov (mentioned by … The NIH RePORTer, has links to all publications in which the grant was mentioned. … The NIH RePORTER lists all publications where the grant number was mentioned.

3. Disposition of Comments for Technical Brief 25 Disparities within Serious Mental Illness (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/mental-illness-disparities_disposition-comments.pdf
   May 26, 2016 - One relatively minor thing I want to mention is that I noticed that the term Latino is mentioned in … I think this group warrants being mentioned by name (even if the authors did not find many studies … The authors may want to consider moving any new lit search terms mentioned in this paragraph to the … In Guiding Question 3 on page 40, line 16-19, there is no N mentioned for the Tsai study. … Remove the phrase, As previously mentioned". Agreed. We made the suggested changes Thank you.

4. Rapid Evidence Product: Misuse of ADHD Prescription Stimulants in Adults (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-adhd-prescription-rapid-research.pdf
   July 01, 2025 - Not reported C-12 Study ID Population ADHD Medications Mentioned Findings—Misuse Patterns … Not reported C-13 Study ID Population ADHD Medications Mentioned Findings—Misuse Patterns … Yes C-21 Study ID Population ADHD Medications Mentioned Findings—Misuse Patterns Findings … No C-27 Study ID Population ADHD Medications Mentioned Findings—Misuse Patterns Findings … Yes C-47 Study ID Population ADHD Medications Mentioned Findings—Misuse Patterns Findings—

5. Disposition of Comments_Comparative Effectiveness Review No. 253: Maternal and Child Outcomes Associated With the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/maternal-child-outcomes-wic-disposition-comments.pdf
   April 19, 2022 - Yes, that is correct and it is mentioned in the discussion that this is not the pattern for US children … This is mentioned in the Methods section under “Data Synthesis and Analysis.” … Importance of the review to stakeholders: Expand on reasons why this review is important to all groups mentioned … WIC Association (NWA) Discussion Incorporation of qualitative studies: Qualitative studies are mentioned … National WIC Association (NWA) Discussion NASEM recommendations: The NASEM recommendations aren’t mentioned

6. Disposition of Comments: Comparative Effectiveness Review No. 273_Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-273-anal-cancer-disposition-comments.pdf
   August 20, 2024 - In the discussion section in the report, it was mentioned that “this does not mean that none of the … better the impact of therapies for localized SCCA on pts survival In the revised report, we have mentioned … We have excluded the sentence mentioned by the reviewer.

7. Rapid Response_The Association Between Outcomes and Dental Services in Persons With Autoimmune Disease Treated With Biologics and Other Immunosuppressants: A Rapid Response Review (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/autoimmune-disease-rapid-research.pdf
   November 01, 2024 - 2018 NICE, Rheumatoid arthritis in adults: diagnosis and management Guideline None mentioned … 2017 NICE, Psoriasis: assessment and management Guideline None mentioned Systemic lupus erythema … colitis: management Guideline No mentioned 2019 NICE, Crohn’s disease: management Guideline Not mentioned … 2018 AGA, Management of mild-to-moderate ulcerative colitis Guideline None mentioned 2018 ACG … Clinical Guideline: Management of Crohn's Disease in Adults Guideline None mentioned 2017 Research

8. Disposition of Comments Report for Evaluation and Treatment of Cryptorchidism (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/undescended-testicle_disposition-comments.pdf
   December 11, 2012 - In many of the studies mentioned in the report, when the testis was identified by US in the inguinal … Thank you Peer Reviewer #1 Results The results section is well described, although as mentioned in … modifying effect of age at the time of treatment and outcomes revealed conflicting reports, which is mentioned … It should be rephrased to reflect that the goal of these modalities would be to perform as mentioned … Peter Lee’s paternity data in adult men gives on children undergoing orchiopexy, not mentioned.

9. CER 217 Disposition of Comments: Management of Infertility (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-management-of-infertility-comments.pdf
   May 14, 2019 - This is mentioned later in the paper. … Peer Reviewer #5 Results Should add the age concern with reference 94—(I see this mentioned on page … This lack of precision should be mentioned as an issue. … these rare outcomes are mentioned in the table on page 54 for example for outcomes of small PRTs and … this should be mentioned as a weakness.

10. Disposition of Comments for CER 178 Newer Medications for Lower Urinary Tract Symptoms (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/prostatic-hyperplasia-medications_disposition-comments.pdf
    May 26, 2016 - This may need to be mentioned in the Key Points section (page 8). … This is mentioned in the text and described in detail in the appendices for each study. … While not key points, these issues are mentioned in the discussion. … We mentioned the lack of blinding in the results section. … A few minor points that would improve clarity were mentioned above.

11. Improving Rural Health Through Telehealth-Guided Provider-to-Provider Communication (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rural-telehealth-disposition-comments.pdf
    December 26, 2022 - Also I don';t think I saw Two-Spirit mentioned. … Also I don't think I saw Two-Spirit mentioned.

12. Disposition of Comments_Comparative Effectiveness Review No. 262_Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-disposition-comments.pdf
    November 07, 2023 - I appreciate that this is mentioned, but feel it could be more strongly emphasized. … We have ensured that contraindications are mentioned early in the report. … consideration of open label trials, which showed benefit of disulfiram, these would not need to be mentioned … Is this the first time standard deviation is mentioned? Also, the SD for both groups is 4.1. … Public Comment #3 (APA) Results In some places it's mentioned why a study is rated as high risk of

13. Disposition of Comments_Technical Brief No. 43: Measuring Healthcare Organization Characteristics in Cancer Care Delivery Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/organization-cancer-care-disposition-comments.pdf
    June 20, 2023 - Mentioned a few organizational theories that feature specific measurement implications. … However, themes of the survey and discussion groups were not mentioned and could be included in the … That was mentioned in the summary and implications section, but not in the methods that I can see. … We mentioned the possible use of the NCCN instrument for equity related measurement in the Guiding … Centralization is mentioned as a term in several places in the report but without definition or “i.e

14. Disposition of Comments_Technical Brief No. 47: Measuring Documentation Burden in Healthcare (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/documentation-burden-prepub-disposition-comments.pdf
    May 21, 2024 - A few topics (as mentioned above) needed more discussion. Thank you. … Was this mentioned. Just curious. … If any of these were mentioned at all, what did it say? … What about all of the other provider types mentioned in the executive summary? … Earlier in the article it mentioned that most studies focused on physicians.

15. Disposition of Comments Report for CER 134 Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_disposition-comments.pdf
    May 13, 2014 - This needs to be mentioned as a strong limitation of this work. … We did find a new quetiapine study that is likely the one mentioned here. … This should be mentioned in text. Thank you. … We do not agree that this study should be mentioned, given the limitations mentioned by the reviewer … For example, the risk of bias was not mentioned for acamprosate.

16. Disposition of Comments for Technical Brief 23 Genetic Testing (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/genetic-testing-developmental-disabilities_disposition-comments.pdf
    June 30, 2015 - General Comments 3) While I understand the focus on disorders mentioned by the key informants, this … Guiding Questions In interventions on page 7, sequencing is mentioned but it’s not clear at this … Now whole exome or genome sequencing are explicitly mentioned. … Nongenetic tests are beyond this Technical Brief’s scope thus not mentioned in the report. … Table 2 – Southern blot not mentioned for Fragile X.

17. Disposition of Comments for CER 162 Diagnosis of Celiac Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/celiac-disease_disposition-comments.pdf
    January 28, 2016 - (This is briefly mentioned at the conclusion of the Executive Summary and at the end of the manuscript … cost and acceptance of biopsy by asymptomatic subjects might make such studies prohibitive; this is mentioned … cost and acceptance of biopsy by asymptomatic subjects might make such studies prohibitive; this is mentioned … nearby and was a member of our technical expert panel, so we are aware of the important study you mentioned … One issue that is not mentioned is the need for even more accurate serologic tests that could supplant

18. Disposition of Comments for CER 168 Infantile Hemangioma (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_disposition-comments.pdf
    January 15, 2016 - Peer reviewer #3 Discussion As mentioned in the review, the threshold for treatment is likely decreasing … TEP reviewer #2 Meta-analysis Page 20 I do not think that intralesional propranolol should be mentioned … or put in figure D; on the other hand triamcinolone is intralesional and should be mentioned in Figure … Prednisone – 29% These numbers are mentioned MANY times throughout the paper and I believe they are … Peer reviewer #4 Results The results section mentioned “a network meta-analysis” in many places – but

19. Disposition of Comments for CER 147 Menopausal Symptoms: Comparative Effectiveness of Therapies (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_disposition-comments.pdf
    March 05, 2015 - Below the first Table 11, Table 12 is mentioned twice, one right after each other. … ES-8 please verify that the definitions of high, low, and standard dose estrogen used in table A is mentioned … Why is liver toxicity of vitamin E not mentioned as an agent-specific toxicity? … possibly pg. 5, Population) that studies involving women with breast cancer were excluded (first mentioned … does not allow referencing all the data of “lesser” quality, but certainly its existence should be mentioned

20. Disposition of Comments for CER 170 Cultural Competence Health Disparities (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cultural-competence_disposition-comments.pdf
    January 01, 2020 - I believe this is the first time any results were mentioned, and the statement is very uninformative … Minimally this population should be mentioned in the research directions section Thank you, persons … Intersectionality is also mentioned throughout the review were relevant. … and discussed in the body of the text, tables, and reference list as well as mentioned in terms of … TEP 1 General As mentioned above, would suggest changing the storyline and chapter order to present